Cite
Messerli SM, Schaefer AM, Zhuang Y, et al. Use of Antimetastatic SOD3-Mimetic Albumin as a Primer in Triple Negative Breast Cancer. J Oncol. 2019;2019:3253696doi: 10.1155/2019/3253696.
Messerli, S. M., Schaefer, A. M., Zhuang, Y., Soltys, B. J., Keime, N., Jin, J., Ma, L., Hsia, C. J. C., & Miskimins, W. K. (2019). Use of Antimetastatic SOD3-Mimetic Albumin as a Primer in Triple Negative Breast Cancer. Journal of oncology, 20193253696. https://doi.org/10.1155/2019/3253696
Messerli, Shanta M, et al. "Use of Antimetastatic SOD3-Mimetic Albumin as a Primer in Triple Negative Breast Cancer." Journal of oncology vol. 2019 (2019): 3253696. doi: https://doi.org/10.1155/2019/3253696
Messerli SM, Schaefer AM, Zhuang Y, Soltys BJ, Keime N, Jin J, Ma L, Hsia CJC, Miskimins WK. Use of Antimetastatic SOD3-Mimetic Albumin as a Primer in Triple Negative Breast Cancer. J Oncol. 2019 Feb 28;2019:3253696. doi: 10.1155/2019/3253696. eCollection 2019. PMID: 30941174; PMCID: PMC6420975.
Copy
Download .nbib